Discover trends, market shifts, and competitive outlooks for the trastuzumab biosimilars industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Trastuzumab Biosimilars Market In 2029?

The size of the trastuzumab biosimilars market has witnessed a massive growth in the past few years. The market, which stood at $4.27 billion in 2024, is projected to reach $5.43 billion in 2025, registering a compound annual growth rate (CAGR) of 27.1%. The impressive growth during the historical phase can be credited to factors like broadening of the market reach globally, expiration of the patent and entry into the market, swift development of biosimilars, validation of clinical efficacy, and competitive pricing strategies.

The market size of trastuzumab biosimilars is projected to undergo significant expansion in the coming years. It is predicted to reach $14.69 billion in 2029, escalating at a compound annual growth rate (CAGR) of 28.3%. The rise during the forecast duration is ascribed to the intensifying market rivalry, development of the biosimilar pipeline, establishment of regulatory approvals and standardizations, penetration of the global market, and patterns of physician adoption and prescribing. The forecast period will observe notable trends like enhanced access to trastuzumab biosimilars, market segmentation plans, informational campaigns, patient favoritism for biosimilars, and physician approval.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3400&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Trastuzumab Biosimilars Market?

The trastuzumab biosimilars market saw an increase due to the escalating instances of breast and gastric cancer. Used for treating human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer and metastatic gastric cancer, trastuzumab biosimilar has seen growing demand. The American Cancer Society, a US-based voluntary health organization focused on cancer eradication, reported in September 2023 that around 297,790 new cases of invasive breast cancer would be diagnosed in women in 2023, leading to approximately 43,700 deaths from breast cancer within the same year. On a similar note, Cancer India states that breast cancer is the predominant cancer in Indian women, composed of 14% of all cancer cases in women. Consequently, the climbing prevalence of breast and gastric cancer heightens the need for trastuzumab biosimilar, offering a less costly alternative to expensive medications, thus propelling the expansion of the trastuzumab biosimilars market.

Which Key Market Segments Comprise the Trastuzumab Biosimilars Market and Drive Its Revenue Growth?

The trastuzumab biosimilars market covered in this report is segmented –

1) By Product: Ogivri, Herzuma, Ontruzant, Trazimera, Other Products

2) By Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Other Indications

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3400&type=smp

Which Areas Are Leading Regions in the Trastuzumab Biosimilars Market Expansion Across the Globe?

The countries covered in the trastuzumab biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Are the Key Market Trends in the Trastuzumab Biosimilars Market Over the Coming Years?

Leading entities are consistently emphasizing on introducing new products in unexplored areas, thereby shaping the trastuzumab biosimilars market. Companies functioning in this market are taking several strategic steps such as developing new products, entering partnerships, and expanding their geographical presence and product portfolio to hold their competitive edge and cater more effectively to consumer requirements. For example, Accord BioPharma Inc., a pharmaceutical company based in the US, declared in April 2024 that it has received approval from the U.S. Food and Drug Administration (FDA) for HERCESSI (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab) used for treating various forms of HER2-Overexpressing Cancer. HERCESSI is recommended for the additional treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Even though HER2-positive cancers are typically aggressive, they exhibit an effective response to targeted therapies. HERCESSI operates by binding to the HER2 receptor, suppressing its activity, and as a result, decelerating the reproduction of cancer cells.

View the full report here:

https://www.thebusinessresearchcompany.com/report/trastuzumab-biosimilar-global-market-report

How Is the Trastuzumab Biosimilars Market Conceptually Defined?

Trastuzumab biosimilar refers to a HER2-targeted therapy drug that is designed to treat early and metastatic HER2-positive breast cancers. Trastuzumab biosimilar is a monoclonal antibody that binds to the human epidermal growth factor receptor 2 (HER2)/neu receptor and renders it inactive

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3400

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model